bm 13505 has been researched along with Injury, Myocardial Reperfusion in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auchampach, JA; Ge, ZD; Gross, GJ; Piper, GM | 1 |
Lefer, AM; Ma, XL; Viehman, GE | 1 |
DiMartino, MJ; Egan, JW; Griswold, DE; Hillegass, LM; Smith, EF | 1 |
Lefer, AM | 1 |
Earl, CQ; Egan, JW; Griswold, DE; Hillegass, LM; Marshall, PJ; Smith, EF | 1 |
Bhat, AM; Lefer, AM; Osborne, JA; Sacks, H | 1 |
6 other study(ies) available for bm 13505 and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists.
Topics: Animals; Benzenesulfonates; Cardiotonic Agents; Cycloheptanes; Dogs; Myocardial Reperfusion Injury; Phenylacetates; Receptors, Thromboxane; Sulfonamides | 2003 |
Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
Topics: Animals; Cats; Coronary Vessels; Endothelium, Vascular; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Peroxidase; Phenylacetates; Sulfonamides; Thromboxanes; Vasoconstriction | 1990 |
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiomyopathies; Creatine Kinase; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes | 1989 |
Role of thromboxane A2 in myocardial ischemia and circulatory shock.
Topics: Animals; Cats; Coronary Disease; Myocardial Reperfusion Injury; Phenylacetates; Platelet Aggregation; Rabbits; Shock; Sulfonamides; Thromboxane A2; Thromboxanes | 1989 |
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Disease; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1989 |
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Topics: Acute Disease; Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylacetates; Sulfonamides; Thromboxanes | 1989 |